2021
DOI: 10.1016/j.mattod.2020.12.005
|View full text |Cite
|
Sign up to set email alerts
|

Nanozyme-involved biomimetic cascade catalysis for biomedical applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
90
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 173 publications
(90 citation statements)
references
References 151 publications
0
90
0
Order By: Relevance
“…Inspired by this, enzyme-medicated cascade catalysis strategy could be developed for DU microenvironment modulation. However, due to the limitation of the specificity of enzyme-catalyzed reactions as well as high cost and harsh usage condition [ 29 ], enzyme cascade catalysis systems with simple composition that can concurrently address the four DU-related issues remain elusive. Recently, investigation on nanozyme has demonstrated that some nanomaterials (e.g., metal-oxide and carbon-based nanoparticles) possess distinctive pathological conditions-switchable multiple enzyme-like activities, indicating the feasibility of employing one nanozyme to catalyze cascade reactions [ 30 33 ].…”
Section: Introductionmentioning
confidence: 99%
“…Inspired by this, enzyme-medicated cascade catalysis strategy could be developed for DU microenvironment modulation. However, due to the limitation of the specificity of enzyme-catalyzed reactions as well as high cost and harsh usage condition [ 29 ], enzyme cascade catalysis systems with simple composition that can concurrently address the four DU-related issues remain elusive. Recently, investigation on nanozyme has demonstrated that some nanomaterials (e.g., metal-oxide and carbon-based nanoparticles) possess distinctive pathological conditions-switchable multiple enzyme-like activities, indicating the feasibility of employing one nanozyme to catalyze cascade reactions [ 30 33 ].…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, combination therapy involving additional therapeutics is necessary. [ 23–28 ] This however complicates fabrication, encapsulation, delivery, and release processes, making it not practical due to poor reproducibility, reduced effectiveness, high side‐effects, and high cost.…”
Section: Introductionmentioning
confidence: 99%
“…It owns efficient mass transfer activities which reduced the intermediate decomposition due to its local production at higher concentrations. [ 1 ] However, strict physiological conditions, selective stability, poor reusability for performing any particular catalytic reactions are the major intrinsic fragility of these naturally occurring enzymes. [ 2 ] In this pursuit, the expansions of nanotechnological advancement have led to the development of nanoscale materials that exactly mimic the “natural‐enzymes” as well as exhibit similar intrinsic properties, popularly known as “nanoenzyme” or “nanoenzyme”.…”
Section: Introductionmentioning
confidence: 99%